[1] Chassaing B, et al. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014 Feb 4;104:15.25.1-15.25.14. [2] Kinchen J, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018 Oct 4;175(2):372-386.e17. [3] Zhang H, et al. Biochanin a ameliorates DSS-induced ulcerative colitis by improving colonic barrier function and protects against the development of spontaneous colitis in the Muc2 deficient mice. Chem Biol Interact. 2024 May 25;395:111014. [4] Dokoshi T, et al. Dermal injury drives a skin to gut axis that disrupts the intestinal microbiome and intestinal immune homeostasis in mice. Nat Commun. 2024 Apr 8;15(1):3009. [5]. Wirtz S, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541-6. [6]. Zhu H, et al. RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer. J Exp Clin Cancer Res. 2017 Jan 5;36(1):2. [7] Parang B, et al. AOM/DSS Model of Colitis-Associated Cancer. Methods Mol Biol. 2016;1422:297-307. [8] Kitajima S, et al. Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp Anim. 2000 Jan;49(1):9-15. [9] Lu G, et al. Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes. Diabetes. 2020 Aug;69(8):1692-1707.